Pharma companies team up to reduce heat-related emissions

Several large pharmaceutical companies, including AstraZeneca, Sanofi, Opella and UCB, have formed the Clean Heat Program, an effort to move away from fossil-fuel-powered heat in manufacturing. Drug production relies heavily on steam, usually generated by natural gas boilers, and these companies are working to swap that out for lower-carbon options like heat pumps (devices that move heat rather than burning fuel to create it) and biomethane. The program also pushes their suppliers to make similar changes, offering technical help and, in some cases, financing support. More than 1,000 sites are already part of the effort.

This is industrial policy news rather than something that changes options available to homeowners directly, but it shows the same technology shift happening in homes — heat pumps and electrification — is also spreading through heavy industry. Opella, the maker of brands like Icy Hot and Allegra, has already cut natural gas use by replacing boilers with heat pumps at plants in Japan, France and Brazil, trimming gas consumption by 20 percent at one site.

The story also points to a less obvious wrinkle: switching to cleaner heat doesn't always make a company's emissions numbers look simpler. Merz Therapeutics replaced oil heating with electric steam production at its German headquarters, cutting onsite emissions by 46 percent. But because it now buys heat from a district energy system, that shows up as an increase in a different emissions category. It is a reminder that accounting for energy upgrades, at any scale, can be more complicated than the simple before-and-after savings number.